Advanced Search
      Login
 
Main Menu



Lung Disease in Women
Author: Gerard Frank, M.D., Ph. D.
Last Revised: Sat, 02-Feb-2002
Article Size: 22.17 KB

PDF version

BRIEF CLINICAL UPDATE

Lung Disease in Women

Gerard Frank, M.D., Ph. D.

In contrast to Rheumatologic Disease, physicians seldom think of lung problems as occurring primarily in women. This is because until recent decades the prevalence of smoking and therefore obstructive lung disease was much less in women. Moreover, women have been less exposed to dusty occupational environments, except for the anecdotal reports of women who washed the asbestos out of their husbands' overalls or dusted themselves excessively with talc powder. Nevertheless, there are a number of pulmonary diseases which either occur more frequently in women or affect women and men differently.

Thromboembolic Disease

Thromboembolic disease is probably the most common important lung problem not related to smoking which affects women. This, of course, is because of the risk conferred by endogenous or exogenous estrogens. Dyspnea in a pregnant woman or one on an oral contraceptive always has to prompt consideration of deep vein thrombosis/pulmonary embolism, especially if the chest x-ray is normal. Blood gases will typically show both low pO2 and pCO2. In diagnosing this disease, compression Doppler studies afford a sensitive and specific noninvasive technique. Nuclear Medicine V/Q scans are feasible during pregnancy if a lower dose of isotope is given. CT angiography is beginning to supercede V/Q scans and is not contraindicated in pregnancy. These patients should be worked up for genetic causes of thrombophilia. One study showed that 60% of pregnant patients who developed thromboemboli had Factor V Leiden.1

In the treatment of this disease, the pregnant women can be started on heparin in the hospital and discharged on subcutaneous low-molecular weight heparin. Prophylaxis of patients at higher risk, either because of previous episodes or one of the various forms of thrombophilia, is more controversial. Warfarin has always been considered teratogenic and contraindicated in pregnancy. In a British study of pregnant patients with prosthetic heart valves, however, warfarin therapy was more effective than heparin in preventing thromboemboic disease, and associated with fewer bleeding complications.2 A meta-analysis of such patients showed a 6.4% incidence of warfarin embryopathy when warfarin was used through the pregnancy. Conversion to heparin during weeks 6-12 eliminated the risk of embryopathy but increased the incidence of thromboembolism from 3.9% to 9.2%.3 The American College of Chest Physicians continues to recommend only heparin as prophylaxis in pregnant patients at higher risk.4

The high-risk woman with a prior episode of DVT or PE who is on chronic warfarin should try to plan pregnancy and be switched to outpatient heparin before conception. With unplanned pregnancy, warfarin should be stopped and heparin started immediately. In the event of significant bleeding from any source, placement of an inferior vena cava filter must be considered.

Amniotic fluid embolism is another condition exclusive to the peripartum patient. Manifesting as acute dyspnea with pulmonary infiltrates and DIC, this diagnosis is made clinically but may be confirmed with aspiration of uterine or fetal cells through a pulmonary artery catheter. It is treated supportively.

Pulmonary Hypertension

Primary or idiopathic pulmonary hypertension (PPH) is well known as a disease of women in the childbearing years, and has been seen in older women on estrogen replacement. While the pathogenesis remains unclear it has been suggested that patients may have increased stimulation of pulmonary vascular smooth muscle by serotonin. The majority of patients with PPH expressed a gene for overexpression of the serotonin transporter (5-HTT) which was also expressed in cultured cell from their lungs.5 PPH was long treated with vasodilators but was relentlessly progressive. Prostacyclin analogs have greatly improved therapy in that they exclusively dilate the pulmonary vessels and lead to less systemic hypotension. At present, such prostaglandins (chiefly iloprost) must be given intravenously or as an inhaled aerosol with a short-lived effect. In a recent study, the effectiveness of inhaled iloprost was enhanced by the addition of oral sildenafil, a phosphodiesterase 5 inhibitor. Sildenaphil (as in penile erection) enhances vasodilating levels of cGMP. 6 Inhaled nitric oxideacts in a similar fashion in the acute setting. Lung or heart-lung transplantation can extend life span in these patients.

Airway Disease

Asthma is increasing in prevalence and more rapidly in women. In the decade 1982-1992 its prevalence in the U.S. increased by 82% in women versus 29% in men.7 While there does not appear to be a gender bias in terms of objective pulmonary function, studies have shown differences between men and women asthmatics in presentation. Women asthmatics enrolled in an HMO were more likely to complain of symptoms, more likely to visit the doctor and generally used more medication.8 While a number of studies concluded that hormones influenced severity of asthma, i.e., relation to menstrual cycle, a study of 288 asthmatic women showed no relation of emergency room visits to menstruation, and only 13% of the patients identified menses as a precipitating factor to their disease.9

Vocal Cord Dysfunction Syndrome is now well recognized and occurs almost exclusively in women, who present with sudden attacks of dyspnea.10 Their stridor is often mistaken for wheezing due to asthma. They rapidly improve after admission. The diagnosis can be confirmed by direct laryngoscopy at the time of the attack showing vocal cord spasm.

Obstructive sleep apnea occurs in both sexes with a male predominance. Studies have shown gender differences, however. For a given measure of obesity (BMI and other indices) women manifest a less severe degree of sleep apnea than men and their apneas are more clustered during REM sleep.11,12 One explanation may relate to the different anatomy of the pharynx, which allows less collapse during exhalation in women as in men.13

Malignancy in the Lung

Primary lung cancer has always been a male-predom-inant disease because of the strong association with smoking. In recent decades, however, the rates of lung cancer in women have been increasing faster than those for men. Lung cancer now kills more women than breast cancer.14 Many studies have looked at the differences in susceptibility to the effects of tobacco between men and women. It seems clear that the risk of lung cancer is higher in women than men for any level of smoking history, at least for small cell or adenocarcinomas. Among patients with squamous cell carcinomas of the lung, however, women are more likely to have been non-smokers than men.15 A study which looked at the relation between diet and lung cancer in women showed increased risk associated with red meat and decreased risk associated with yellow-green vegetables.16

Because of the tendency of breast cancer to metastasize to the lung, it should be suspected in a woman without symptoms who has nodules on chest x-ray. Breast cancer also frequently causes malignant pleural effusions as can ovarian carcinoma.

Thymoma, which is seen in 15% of patients with myasthenia gravis will more often be found in a woman, and represents one example of an important type of anterior mediastinal mass, others being substernal goiter, germ cell tumor and lymphoma. In a study of outcomes after thymectomy in patients with myasthenia, 79% of the patients were women.17 Female sex was associated with a more favorable outcome in terms of amelioration of the myasthenia.

Pleural Effusion

Pleural effusions are a frequent manifestation of rheumatoid disease, particularly in SLE, a predominantly female disease. Curiously, in Rheumatoid Arthritis, pleural effusions tend to occur mostly in males.

Lymphangioleiomyomatosis (LAM) affects women in the child-bearing years and occasionally seniors on ERT. It causes milky chylous (high triglycerides) pleural effusions because of lymphatic obstruction in the lung. The underlying pathology is an abnormal proliferation of lymphatic smooth muscle. These patients can also suffer spontaneous pheumothorax. Their chest x-rays are characterized by large lung volumes with obstructive defects on pulmonary function testing. High resolution CT scans in LAM are very characteristic with large cystic spaces surrounded by areas of increased interstitial markings. LAM appears to be related to Tuberous Sclerosis. One-third of female patients with Tuberous Sclerosis were found to have the characteristic CT scan features of LAM.18 Sporadic cases of LAM have been shown to possess mutations in the Tuberous Sclerosis Complex gene TSC2.19 In common with Tuberous Sclerosis, patients with sporadic LAM have a high incidence of meningiomas.20

Meig's Syndrome is the association of a pleural effusion with a pelvic tumor in women. The originally described tumors were benign, but such effusions arenow known to occur with malignancies in the pelvis as well, and their presence appears to correlate with the size of the primary. The effusions themselves are benign but may be bloody. There may be ascites as well. While sometimes bilateral they occur most frequently on the right side. Removal of the primary tumor usually results in resolution of the effusion.

The "ovarian overstimulation syndrome" induced by exogenous human chorionic gonadotropin can cause unilateral or bilateral pleural effusions. Patients usually present with abdominal distension, nausea and dyspnea. Yellow Nail Syndrome is another lymphatic disease in which patients, primarily women, develop pleural effusions, lymphedema, bronchiectasis, and yellowish nails.

Pneumothorax

Besides LAM as a cause of spontaneous pneumothorax in women, there is another syndrome exclusive to women known as Catamenial Pneumothorax. At the time of menstruation, these women may become acutely short of breath and experience spontaneous pneumothorax, almost always on the right. The etiology has been ascribed both to diaphragmatic fenestration and endometriosis in the lung with breakdown of the tissue causing lung rupture.21,22 Patients may also experience hemoptysis. This disease has been treated with medical oophorectomy using agents such as danazol or GRH. More current approaches include minimally invasive surgery using thora-coscopy.23

Tuberculosis

Interestingly, during both the rise and decline of TB prevalence, regardless of ethnicity, both the incidence and severity of TB in women has been consistently less than in men.24 This was confirmed in a recent San Francisco study, which showed a male to female ratio of 2:1 in primary TB. The age-specific rates were also greater for males in those with reactivation disease.25 The relatively few studies of gender differences in TB have generally come from Third World countries. These studies suggest differences in diagnosis, treatment and societal perceptions of TB in women, usually to their disadvantage, and reflecting their lower social status in many societies.26 The authors of this study concluded that the differences in rates were probably due to transmission dynamics rather than diagnosis or reporting biases. Women present special problems in the treatment of TB. Latent TB (exposure only, no active disease) is often detected during pregnancy with PPD skin testing. Such patients are at higher risk of hepatotoxicity due to isoniazid and prophylaxis should be delayed until about three months post-partum or until breast-feeding stops. The pregnant patient with active or strongly suspected active disease should be treated in the usual way (four drug regimen) with careful monitoring of hepatic function. The neonate should be followed with monthly PPD skin tests (as well as all other close contacts).

Pulmonary Edema

In addition to causing effusions, SLE may present as non-cardiogenic pulmonary edema (Lupus Pneumonitis). It presents similarly to ARDS, but may respond to high-dose steroids and cyclophos-phamide.27 In the peri-partum period, women may develop acute pulmonary edema after the use of beta-adrenergic tocolytics such as terbutaline or isoxuprine. There is no specific treatment other than supportive care.

Interstitial Lung Disease

Scleroderma, a predominatly female disease, is the rheumatologic condition with most frequent lung involvement. Most scleroderma patients at autopsy show pulmonary fibrosis. Because of their esophageal motility abnormalities, scleroderma patients may also be chronic aspirators. Scleroderma patients may give evidence of air trapping on pulmonary function testing. However, their elevated residual volumes are not due to airway obstruction but rather to abdominal muscle weakness which prevents a normal maximal exhalation. Pulmonary hypertension is a frequent end-stage complication of scleroderma. A Japanese study

(M:F = 9:1) suggested that there are subsets of scleroderma patients in whom pulmonary hypertension is the direct result of the fibrotic change, and others where it results from an arteriopathy.28 Severity of the lung disease in terms of function has been shown to be associated with antibodies to tropoisomerase I and the frequency of such antibodies was higher in African-Americans (M:F = 3:1).29 Sjogren's syndrome is also associated with the development of lymphocytic interstitial pneumonia (LIP) and may rarely progress to lymphoma.

Chronic eosinophilic pneumonia is an uncommon disease occurring typically in middle-aged women who may present with productive cough, wheezing, fevers, sweats and weight loss. Eosinophils may bepresent either in the peripheral blood or bronchoalveolar lavage fluid and the sedimentation rate tends to be high. The x-ray typically shows peripheral and fleeting infiltrates often described as the "photographic negative" of pulmonary edema. One study with long-term follow up showed a dramatic response of this condition to corticosteroids but with frequent relapses when therapy was withdrawn.30 In this group of women prognosis was good but therapy with corticosteroids was often required for years.

Conclusion

There are thus a wide variety of pulmonary conditions found exclusively or primarily in women. This review will hopefully alert the primary clinician and raise the index of suspicion for these conditions.

REFERENCES

  1. Hellgren M, Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 1995 Jul;173(1):210-213.

  2. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J. 1994 Feb;71(2):196-201.

  3. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000 Jan 24;160(2):191-196.

  4. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001 Jan;119(1 Suppl):122S-131S.

  5. Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter over-expression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001 Oct;108(8):1141-1150.

  6. Wilkens H, Guth A, Konig J, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation. 2001 Sep 11;104(11):1218-1222.

  7. Asthma-United States, 1982-1992. MMWR Morb Mortal Wkly Rep. 1995 Jan 6;43(51-52):952-955.

  8. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998 Jan;157(1):123-128.

  9. Zimmerman JL, Woodruff PG, Clark S, Camargo CA. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):512-515.

  10. Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1382-1386.

  11. Millman RP, Carlisle CC, McGarvey ST, Eveloff SE, Levinson PD. Body fat distribution and sleep apnea severity in women. Chest. 1995 Feb;107(2):362-366.

  12. O'Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med. 2000 May;161(5):1465-1472.

  13. Brooks LJ, Strohl KP. Size and mechanical properties of the pharynx in healthy men and women. Am Rev Respir Dis. 1992 Dec;146(6):1394-1397.

  14. Ernster VL. Female lung cancer. Annu Rev Public Health. 1996;17:97-114.

  15. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996 Feb 21;88(3-4):183-192.

  16. Alavanja MC, Field RW, Sinha R, et al. Lung cancer risk and red meat consumption among Iowa women. Lung Cancer. 2001 Oct;34(1):37-46.

  17. Budde JM, Morris CD, Gal AA, Mansour KA, Miller JI Jr. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg. 2001 Jul;72(1):197-202.

  18. Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001 Aug 15;164(4):669-671.

  19. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-6090.

  20. Moss J, DeCastro R, Patronas NJ, Taveira-DaSilva A. Meningiomas in lymphangioleiomyomatosis. JAMA. 2001 Oct 17;286(15):1879-1881.

  21. Cowl CT, Dunn WF, Deschamps C. Visualization of diaphragmatic fenestration associated with catamenial pneumothorax. Ann Thorac Surg. 1999 Oct;68(4):1413-1414.

  22. Fonseca P. Catamenial pneumothorax: a multifactorial etiology. J Thorac Cardiovasc Surg. 1998 Nov;116(5):872-873.

  23. Tripp HF, Thomas LP, Obney JA. Current therapy of catamenial pneumothorax. Heart Surg Forum. 1998;1(2):146-149.

  24. World Health Organization. Global tuberculosis control, WHO Report, 2000. WHO Publication No. 2000.275.

  25. Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. Int J Tuberc Lung Dis. 2000 Jan;4(1):26-31.

  26. Thorson A, Diwan VK. Gender inequalities in tuberculosis: aspects of infection, notification rates, and compliance. Curr Opin Pulm Med. 2001 May;7(3):165-169.

  27. Cheema GS, Quismorio FP Jr. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med. 2000 Sep;6(5):424-429.

  28. Murata I, Takenaka K, Yoshinoya S, et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest. 1997 Jan;111(1):36-43.

  29. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest. 1998 Sep;114(3):801-807.

  30. Naughton M, Fahy J, FitzGerald MX. Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest. 1993 Jan;103(1):162-165.



Lung Disease in Women
© copyright 2009 Stephen Ng & UCLA Department of Medicine


© 2004-2009, Department of Medicine, UCLA
All rights reserved. We make no representations whatsoever about any other Web site that may be accessed through this site. When you access a non-DOM Web site, please understand that it is independent from our organization, and that we have no control over the content of that Web site
for patient related questions email:access@mednet.ucla.edu
for medical school admission info email:somadmiss@mednet.ucla.edu
for questions about this website email:DOMhelp@mednet.ucla.edu